Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| E Qure Corporation (CE) | EQUR | OTCMarkets | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.0002 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.0002 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 0.0002 - 0.0399 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.0002 | USD |
E Qure Corporation (CE) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 9.36k | 46.79M | 24.13M | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
E Qure (CE) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 10/06/2023 | 08:45 | Edgar (US Regulatory) | Form REVOKED - Commission order revoking Exchange Act.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EQUR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.0003 | 0.0399 | 0.0002 | 0.0087657 | 3,978 | -0.0001 | -33.33% |
| 3 Years | 0.0505 | 0.065 | 0.0002 | 0.0317237 | 20,722 | -0.0503 | -99.60% |
| 5 Years | 0.125 | 0.16 | 0.0001 | 0.0433566 | 15,793 | -0.1248 | -99.84% |
E Qure (CE) Description
| E-Qure Corp. is engaged in the development and commercialization of its patented Bio-electrical Signal Therapy or BST Device, a new electrotherapy for the noninvasive treatment of hard to heal chronic wounds using electrical simulation to promote renewed blood flow and oxygen in order to induce local cell regeneration. The BST Device, designed to address limitations of competitors' wound care devices, is used to treat chronic wounds, primarily Stage III and Stage IV ulcers, and severe Stage II wounds. Our BST Device has received: (i) regulatory approval and CE certification permitting sale in the European Union markets; (ii) official certification from the Israeli Ministry of Health for use of the BST Device in Israel. The Company has entered into distribution agreements with third parties to market and sell its BST Device in several countries and is in the process of developing world-wide distribution arrangements. Company will launch a double arm, randomized clinical trial (RCT - Randomized Control Trial) in Israel to help promote the use of the BST device with local health care providers. |
